VCRE is Vicore Pharma Holding AB (publ) (Healthcare) — a non-dividend-paying stock. Trading at $11.55. Market cap: $316M.
Stock snapshot
| Price | $11.55 |
| Market cap | $316M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About VCRE
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Related non-dividend companies
Other non-dividend stocks investors research alongside VCRE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VCRE's current stock price?
VCRE (Vicore Pharma Holding AB (publ)) is currently trading at $11.55.
Does VCRE pay a dividend?
VCRE (Vicore Pharma Holding AB (publ)) does not currently pay a regular dividend.
Track VCRE in DiviDrip
Add VCRE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VCRE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.